Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 10, 2017

Study Completion Date

March 10, 2017

Conditions
Drug OverdoseOverdose of Beta-adrenergic Blocking DrugBlood Pressure
Interventions
DRUG

metoprolol

One hundred and twenty ml, 0.5 mg metoprolol/ml (as metoprolol tartrate) is administered as an intravenous bolus injection followed by a continuous infusion. Infusion is halted if heart rate drops below 35 bpm or systolic blood pressure drops below 80 mm Hg, or the participant experiences subjective side effects. Infusion stops at T=30 minutes.

DRUG

intravenous lipid emulsion

Intravenous lipid emulsion 20 % is administered as an intravenous bolus infusion (1.5 ml/kg) followed by continuous infusion (infusion rate: 0.25 ml/kg/min). Lipid emulsion infusion is stopped at T = 30 minutes.

DRUG

Sodium chloride 0.9% solution - lipid emulsion dummy

Isotonic 0.9 % sodium chloride solution is administered as an intravenous bolus infusion (1.5 ml/kg), followed by continuous infusion (infusion rate: 0.25 ml/kg/min). Infusion is stopped at T = 30 minutes.

DRUG

Sodium chloride 0.9% solution - metoprolol dummy

Saline solution is administered as an intravenous bolus injection followed by a continuous infusion to T=30 minutes.

Trial Locations (1)

2400

Bispebjerg University Hospital Copenhagen, Copenhagen Northwest

All Listed Sponsors
lead

Mikkel Bring Christensen

OTHER

NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. | Biotech Hunter | Biotech Hunter